Transmission of meropenem in breast milk |
| |
Authors: | Sauberan Jason B Bradley John S Blumer Jeffrey Stellwagen Lisa M |
| |
Institution: | Department of Pharmacy, University of California, San Diego Medical Center and UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences, San Diego, CA, USA. jsauberan@ucsd.edu |
| |
Abstract: | A case is presented of a breast-feeding mother receiving meropenem treatment for a postpartum urinary tract infection caused by extended-spectrum beta-lactamase producing Escherichia coli. Five milk samples were collected in a 48-hour period during meropenem therapy. The average and maximum meropenem concentrations in milk were 0.48 and 0.64 μg/mL, respectively. Based on the maximum concentration, the calculated infant daily exposure from breast milk was 97 μg/kg/d, and the infant weight-adjusted percentage of maternal dosage was 0.18%. There were no dermatologic or gastrointestinal side effects noted in the breastfed infant. Meropenem appears to be acceptable to use during breast-feeding. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|